TREX1 cytosolic DNA degradation correlates with autoimmune disease and cancer immunity
Clinical and Experimental Immunology · 24.03.2023 · 211 (3) · 193-207
DOI: 10.1093/cei/uxad017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 06.02.2023. Verfasst von Liwei Fang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurorehabilitation Center, Pediatric Department, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Autoimmune Diseases, Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Institute for Translational Medicine of Anhui Province, Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
The N-terminal domain of Three Prime Repair Exonuclease 1 (TREX1) is catalytically active and can degrade dsDNA or ssDNA in the cytosol, whereas the C-terminal domain is primarily involved in protein localization. TREX1 deficiency induces cytosolic DNA accumulation as well as activation of the cGAS-STING-IFN signaling pathway, which results in tissue inflammation and autoimmune diseases. Furthermore, TREX1 expression in cancer immunity can be adaptively regulated to promote tumor proliferation, making it a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Neurorehabilitation Center, Pediatric Department, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
- Department of Plastic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
ORCID-Profile: Songcheng Ying, De Wu
Förderung
- Institute for Translational Medicine of Anhui Province
- Natural Science Foundation of Anhui Province
Zitieren
APA
Fang, L., Ying, S., Xu, X., & Wu (2023). TREX1 cytosolic DNA degradation correlates with autoimmune disease and cancer immunity. Clinical and Experimental Immunology, 211(3), 193-207. https://doi.org/10.1093/cei/uxad017
Vancouver
Fang L, Ying S, Xu X, Wu. TREX1 cytosolic DNA degradation correlates with autoimmune disease and cancer immunity. Clinical and Experimental Immunology. 2023;211(3):193-207. doi:10.1093/cei/uxad017
BibTeX
@article{Fang2023,
author = {Fang, Liwei and Ying, Songcheng and Xu, Xi and Wu, De},
title = {TREX1 cytosolic DNA degradation correlates with autoimmune disease and cancer immunity},
journal = {Clinical and Experimental Immunology},
year = {2023},
volume = {211},
number = {3},
pages = {193--207},
doi = {10.1093/cei/uxad017}
}
EUVIMED